Highlights

Cancer drug advances to phase II clinical trials

Cancer drug advances to phase II clinical trials

A New Zealand cancer drug developed by two Maurice Wilkins Centre investigators has reached the second phase of clinical tria...

read the full story

Stepping up the fight: The Tuberculosis Flagship (2013)

Stepping up the fight: The Tuberculosis Flagship (2013)

The Maurice Wilkins Centre is behind the launch of a national research network of ‘serious intellectual muscle’ that aims to ...

read the full story

New chemistry transforms cancer vaccine (2013)

New chemistry transforms cancer vaccine (2013)

A new kind of chemistry that dramatically simplifies the manufacture of cancer vaccines was created this year by Honours stud...

read the full story

Partnerships boost business: MWC supports Auckland Clinical Studies (2013)

Partnerships boost business: MWC supports Auckland Clinical Studies (2013)

The Maurice Wilkins Centre provides world-class support for medical trials provider Auckland Clinical Studies, helping to cem...

read the full story

A licence to manufacture medicines (2012)

A licence to manufacture medicines (2012)

A licence to manufacture medicines has been granted to a University of Auckland facility that will produce the active ingredi...

read the full story

New Zealand patients trial local cancer drug (2012)

New Zealand patients trial local cancer drug (2012)

Cancer patients in Auckland, Waikato and the United States are participating in the first clinical trial of an exciting new d...

read the full story

New Zealand TB drug candidate selected (2012)

New Zealand TB drug candidate selected (2012)

In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidat...

read the full story

New drug targets treatment-resistant cancer (2011)

New drug targets treatment-resistant cancer (2011)

A new drug targeting an important group of cancer cells attracted international funding in 2011 and will soon enter clinical ...

read the full story

Dissecting drug side effects offers hope (2011)

Dissecting drug side effects offers hope (2011)

Researchers from the Maurice Wilkins Centre have discovered how a common class of medicines causes diabetes-like symptoms, an...

read the full story

Cancer stealth drug enters clinical development (2010)

Cancer stealth drug enters clinical development (2010)

The first of an exciting new class of anticancer drugs will proceed to clinical development under an international deal annou...

read the full story

Joining forces against infectious disease (2010)

Joining forces against infectious disease (2010)

The 2010 Superbugs Symposium convened by the Maurice Wilkins Centre brought together more than 350 medical professionals and ...

read the full story

Drug selection a milestone for spin-out (2010)

Drug selection a milestone for spin-out (2010)

In 2010 Maurice Wilkins Centre investigators Professors Bill Denny and Peter Shepherd selected a new anticancer drug candidat...

read the full story

Creating connections between drug discovery and business (2009)

Creating connections between drug discovery and business (2009)

The Maurice Wilkins Centre hosted the New Zealand Drug Discovery Symposium in September 2009, bringing together more than 450...

read the full story

Help with difficult diagnoses (2009)

Help with difficult diagnoses (2009)

Maurice Wilkins Centre technology is helping Auckland Hospital with difficult diagnoses. 

read the full story